Reassessment Needed: Antibiotic Prophylaxis in Dental Procedures Post Total Joint Arthroplasty

The longstanding practice of prescribing antibiotic prophylaxis before dental procedures in patients with prosthetic joints faces scrutiny in light of recent findings. Initially rooted in guidelines to prevent infective endocarditis, the use of antibiotic prophylaxis has expanded to encompass various patient populations, particularly those with total joint arthroplasty (TJA). The historical reliance on this preventive measure is now challenged by a growing body of evidence.

Conflicting Recommendations and Practice Patterns

Despite the historical precedence, recommendations regarding antibiotic prophylaxis before invasive dental procedures have been inconsistent. Both the American Dental Association (ADA) and the American Association of Orthopaedic Surgeons have issued multiple, often conflicting, guidelines over the past 30 years. Current practice patterns reveal a divide, with over 90% of orthopedic surgeons advocating for antibiotic prophylaxis, creating a dilemma for patients who receive conflicting advice from their orthopedic surgeons and dentists.

Inappropriate Antibiotic Prescribing at Dental Visits Incurs Annual Costs of $31 Million

Recent studies, including a 2017 case-control study in Taiwan and a 2022 case-crossover study in the UK, challenge the association between invasive dental procedures and periprosthetic joint infection (PJI). These studies, designed with greater statistical power, question the need for routine antibiotic prophylaxis. The emphasis shifts to improving oral hygiene, especially in individuals with poor oral health and prosthetic joints, as a more effective preventive measure.

Risks Outweighing Benefits

Concerns about antibiotic resistance and adverse events associated with prophylactic antibiotic use add weight to the argument against routine antibiotic prophylaxis. The risk of community-acquired C. difficile infections, particularly in individuals over 65, raises alarms. Recent investigations highlight adverse reactions and deaths associated with specific antibiotics, prompting reconsideration of prophylactic choices.

Several countries, including Australia, Brazil, Canada, Denmark, France, Netherlands, Norway, Portugal, and the United Kingdom, have already abandoned the practice of recommending antibiotic prophylaxis for invasive dental procedures in prosthetic joint patients. Their experiences indicate no increase in late PJI incidence. The evidence from these countries, coupled with concerns about antibiotic resistance, calls for a paradigm shift in approaching antibiotic prophylaxis for patients with prosthetic joints undergoing invasive dental procedures.

Study Indicates ARESTIN Antibiotic Reduces Periodontitis Pathogens

Rethinking Antibiotic Prophylaxis

The accumulated evidence and global practices suggest a need for a reassessment of the current approach to antibiotic prophylaxis in patients with prosthetic joints undergoing dental procedures. The call to cease routine antibiotic prophylaxis aligns with harm reduction efforts and prioritizes patient safety. 

As the conversation unfolds, the dental and orthopedic communities face the challenge of reconciling historical practices with emerging evidence, all in the pursuit of better patient outcomes.